At its annual meeting, The American Association for Clinical Chemistry (AACC) announced that Ping Wang, PhD, DABCC, FACB, Associate Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania and Director of the Clinical Chemistry Section and Core Laboratory, will serve as the 2017 President of American Board of Clinical Chemistry.

The American Board of Clinical Chemistry (ABCC), part of the AACC and incorporated in 1950, is a non-profit organization devoted to certification of individuals with doctoral-level degrees in the practice of clinical chemistry, toxicological chemistry, and molecular diagnostics by establishing standards of competence for those who practice clinical laboratory medicine, and to certify as Diplomates those qualified specialists who comply with the requirements of the Board.

Dr. Wang holds a PhD in Molecular and Cellular Pharmacology from the University of Wisconsin-Madison, trained in Clinical Chemistry at the University of California San Francisco, and joined the Department of Pathology and Laboratory Medicine in 2016 from Houston Methodist Hospital. Her clinical interests include automation, clinical mass spectrometry and CLIA lab operation. Her research interests focus on novel technologies for precision based diagnosis and prognosis.